Recently, new targets of CAR T cells in glioma: podoplanin (PDPN), a member of type I transmembrane glycoproteins, as well as CD70, one of the tumor necrosis factor receptors have been recognized [60,61]. This evidence concerns the gene PDPN and central nervous system cancer.